Occurrence of complications was significantly fewer in the intervention group at baseline and at 6 month follow-up compared to the control group ( baseline : 42.0 % versus 82.1 % , p = 0.003 ; 6 month follow-up : 48.4 % versus 87.0 % ; p = 0.006 ) .